Morf4 family-associated protein 1 (MRFAP1)

Morf4 family-associated protein 1 (MRFAP1) is an intracellular protein encoded by the MRFAP1 gene in humans[3][6]. It interacts primarily with members of the MORF4/MRG (Mortality Factor on Chromosome 4/MORF4-Related Gene) family, especially MORF4L1, as well as with the tumor suppressor retinoblastoma protein (Rb)[3][1][4]. MRFAP1 contains an N-terminal MRG-binding domain, allowing it to bind MORF4L1, and appears to regulate the interaction of MORF4L1 with chromatin-modifying enzymes by competing with other partners such as MRGBP[2]. This modulation may play roles in chromatin modification, histone acetylation, and, by extension, gene regulation and cell differentiation, particularly during spermatogenesis[2]. Expression is highest in testis (notably in spermatogonia), brain, ciliated epithelia, and neurons[2][5]. MRFAP1 is rapidly degraded under normal conditions via the ubiquitin-proteasome system; its stability is increased by inhibition of the NEDD8 pathway (e.g., MLN4924)[2]. While it is associated with cell cycle regulation and has links to disease phenotypes such as cancer (through modulation of histone modifications), there is currently no evidence that it is a direct therapeutic target, receptor, or enzyme. No known direct interacting drugs or clinical biomarkers have been established, and notable safety concerns or therapeutic challenges have not been reported.

Other names

PAM14PGR1Protein associated with MRG of 14 kDaMorf4 family associated protein 1MRG- and Rb-associated proteinProtein PGR1

Indirect stabilization of MRFAP1 by inhibition of NEDD8 pathway (MLN4924 blocks degradation by ubiquitin-proteasome system)[2]